Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ASNA1 Antikörper

ASNA1 Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7254112
  • Target Alle ASNA1 Antikörper anzeigen
    ASNA1 (ArsA Arsenite Transporter, ATP-Binding, Homolog 1 (ASNA1))
    Reaktivität
    • 43
    • 12
    • 10
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Human, Maus
    Wirt
    • 38
    • 4
    • 1
    Kaninchen
    Klonalität
    • 40
    • 3
    Polyklonal
    Konjugat
    • 22
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ASNA1 Antikörper ist unkonjugiert
    Applikation
    • 26
    • 17
    • 13
    • 13
    • 7
    • 6
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC)
    Produktmerkmale
    Polyclonal Antibody
    Aufreinigung
    Antigen affinity purification
    Immunogen
    Fusion protein of human ASNA1
    Isotyp
    IgG
    Top Product
    Discover our top product ASNA1 Primärantikörper
  • Applikationshinweise
    IHC 1:50-1:200, ELISA 1:5000-1:10000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.26 mg/mL
    Buffer
    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    ASNA1 (ArsA Arsenite Transporter, ATP-Binding, Homolog 1 (ASNA1))
    Andere Bezeichnung
    ASNA1 (ASNA1 Produkte)
    Hintergrund
    ASNA1 (also known as TRC40) is a highly conserved ATPase involved in efflux of arsenite and antimonite. Reduced ASNA1 expression is associated with significant inhibition of cell growth,increased apoptosis and increased sensitivity to cisplatin and arsenite.Thus ASNA1 is proposed to be a target to overcome resistance to cancer chemotherapy. In addition,ASNA1 has been identified as an ER targeting factor for tail-anchored proteins in the posttranslational membrane insertion pathway.
    UniProt
    O43681
    Pathways
    Positive Regulation of Peptide Hormone Secretion
Sie sind hier:
Kundenservice